Olgu Sunumu
BibTex RIS Kaynak Göster

Covid-19 Reinfection Dynamics-Is Immunity Short Lasting? Case Series of Healthcare Workers

Yıl 2021, Cilt: 11 Sayı: 02, 105 - 107, 15.06.2021
https://doi.org/10.5799/jmid.951616

Öz

The rapidly spreading Covid-19 pandemic resulted in more than 4.7 million cases diagnosed and 78,727 deaths on September 14, 2020. SARS-CoV-2 was first expected to induce a monophasic disease with at least transient immunity. Here we report a case series of five cases of RT-PCR proved reinfection of Covid-19 in health care workers. On returning to work they might experience a Covid-19 “recurrence” or “reactivation” with increased severity of symptoms after a median symptom-free interval requiring hospitalization which raises the question is the immunity short-lasting. Further studies are required to fully understand the effect of Covid-19 on the immunity of humans in the community. J Microbiol Infect Dis 2021; 11(2):105-107.

Kaynakça

  • 1. Kiyuka PK, Agoti CN, Munywoki PK, et al. Human coronavirus NL63 molecular epidemiology and evolutionary patterns in rural coastal Kenya. J Infect Dis. 2018; 217(11):1728-1739.
  • 2. Tang F, Quan Y, Xin ZT, et al. Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study. J Immunol. 2011; 186(12):7264-7268.
  • 3. Ye G, Pan Z, Pan Y, et al. Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation. J Infect 2020 80(5):e14-e17.
  • 4. Grifoni A, Weiskopf D, Ramirez SI, et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 2020;181(7):1489-1501.e15.
  • 5. Xiao AT, Tong YX, Zhang S. Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients. Clin Infect Dis 2020; 19;71(16):2249-2251.
  • 6. Gousseff M, Penot P, Gallay L, et al. Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound? J Infect 2020; 81(5):816-846.
  • 7. Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020; 71(16):2027-2034.
  • 8. Ling Y, Xu SB, Lin YX, et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl) 2020; 133(9):1039-1043.
Yıl 2021, Cilt: 11 Sayı: 02, 105 - 107, 15.06.2021
https://doi.org/10.5799/jmid.951616

Öz

Kaynakça

  • 1. Kiyuka PK, Agoti CN, Munywoki PK, et al. Human coronavirus NL63 molecular epidemiology and evolutionary patterns in rural coastal Kenya. J Infect Dis. 2018; 217(11):1728-1739.
  • 2. Tang F, Quan Y, Xin ZT, et al. Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study. J Immunol. 2011; 186(12):7264-7268.
  • 3. Ye G, Pan Z, Pan Y, et al. Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation. J Infect 2020 80(5):e14-e17.
  • 4. Grifoni A, Weiskopf D, Ramirez SI, et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 2020;181(7):1489-1501.e15.
  • 5. Xiao AT, Tong YX, Zhang S. Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients. Clin Infect Dis 2020; 19;71(16):2249-2251.
  • 6. Gousseff M, Penot P, Gallay L, et al. Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound? J Infect 2020; 81(5):816-846.
  • 7. Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020; 71(16):2027-2034.
  • 8. Ling Y, Xu SB, Lin YX, et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl) 2020; 133(9):1039-1043.
Toplam 8 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Olgu Sunumu
Yazarlar

Alamgir Khan Bu kişi benim

Manohar Kachare Bu kişi benim

Nagesh Mane Bu kişi benim

Yayımlanma Tarihi 15 Haziran 2021
Yayımlandığı Sayı Yıl 2021 Cilt: 11 Sayı: 02

Kaynak Göster

APA Khan, A., Kachare, M., & Mane, N. (2021). Covid-19 Reinfection Dynamics-Is Immunity Short Lasting? Case Series of Healthcare Workers. Journal of Microbiology and Infectious Diseases, 11(02), 105-107. https://doi.org/10.5799/jmid.951616
AMA Khan A, Kachare M, Mane N. Covid-19 Reinfection Dynamics-Is Immunity Short Lasting? Case Series of Healthcare Workers. J Microbil Infect Dis. Haziran 2021;11(02):105-107. doi:10.5799/jmid.951616
Chicago Khan, Alamgir, Manohar Kachare, ve Nagesh Mane. “Covid-19 Reinfection Dynamics-Is Immunity Short Lasting? Case Series of Healthcare Workers”. Journal of Microbiology and Infectious Diseases 11, sy. 02 (Haziran 2021): 105-7. https://doi.org/10.5799/jmid.951616.
EndNote Khan A, Kachare M, Mane N (01 Haziran 2021) Covid-19 Reinfection Dynamics-Is Immunity Short Lasting? Case Series of Healthcare Workers. Journal of Microbiology and Infectious Diseases 11 02 105–107.
IEEE A. Khan, M. Kachare, ve N. Mane, “Covid-19 Reinfection Dynamics-Is Immunity Short Lasting? Case Series of Healthcare Workers”, J Microbil Infect Dis, c. 11, sy. 02, ss. 105–107, 2021, doi: 10.5799/jmid.951616.
ISNAD Khan, Alamgir vd. “Covid-19 Reinfection Dynamics-Is Immunity Short Lasting? Case Series of Healthcare Workers”. Journal of Microbiology and Infectious Diseases 11/02 (Haziran 2021), 105-107. https://doi.org/10.5799/jmid.951616.
JAMA Khan A, Kachare M, Mane N. Covid-19 Reinfection Dynamics-Is Immunity Short Lasting? Case Series of Healthcare Workers. J Microbil Infect Dis. 2021;11:105–107.
MLA Khan, Alamgir vd. “Covid-19 Reinfection Dynamics-Is Immunity Short Lasting? Case Series of Healthcare Workers”. Journal of Microbiology and Infectious Diseases, c. 11, sy. 02, 2021, ss. 105-7, doi:10.5799/jmid.951616.
Vancouver Khan A, Kachare M, Mane N. Covid-19 Reinfection Dynamics-Is Immunity Short Lasting? Case Series of Healthcare Workers. J Microbil Infect Dis. 2021;11(02):105-7.